ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 39 of 41
Up
УЖМБС 2017, 2(3): 220–228
https://doi.org/10.26693/jmbs02.03.220
Biology

Pro- and Antiphlogistic Concentration of Cytokines in Rats’ Serum after Long-Term Administration of Omeprazole and the Simultaneous Injection of Multiprobiotics and Omeprazole

Pylypenko S. V.
Abstract

Nowadays, the literature data about the role of cytokines in stomach and intestines phlogistic processes develops against the backdrop of long hypoacidity of gastric juice in the absence of H. pylori infection is limited and applies only to certain cytokines. The aim – to explore the balance of pro- and antiphlogistic cytokines in the rats blood serum during long hypoacidity of gastric juice and the impact of multiprobiotics. Objects and methods. The research conducted on nonlinear white male rats with an initial weight 160-180 g, divided into four groups with 10 animals in each. Rats in group I served as control objects. They were intraperitoneally (i/o) administered 0.5 ml of water for injection within 28 days. The rats in Group II were daily intraperitoneally (i/o) injected omeprazole (produced by "Sigma-Aldrich" USA) at a dose of 14 mg/kg, dissolved in 0.2 ml of water for injection. The animals of the third group were once a day during 28 days administered multiprobiotic "Symbiter® acidophilic" concentrated (Symbiter together and omeprazole). Animals of the fourth group were administered omeprazole together with multiprobiotic "Apibakt® once a day during 28 days. "Multiprobiotics Symbiter and Apibact (produced by SPC "O.D. Prolisok", Ukraine) were administered together with omeprazole n/a dose of 140 mg/kg (1,4 * 1010 CFU/kg). Results and discussion. As a result we identified that after 28 days of administration of omeprazole concentration of pro-inflammatory cytokine IFN-γ increased by 58,5% (p <0,05). The group of rats given the long-term co-administration of omeprazole and multiprobiotic "Symbiter" showed IFN-γ concentration in the serum at the level of 30,8% (p <0,05) which is lower in comparison with the group of rats which were administered omeprazole alone. After a 28-day co-administration of omeprazole and multiprobiotic "Apibact" IFN-γ concentration in the serum of the rats was at 24,6% (p <0,05) which is lower in comparison with the group of rats administered one of omeprazole and 19, 5% (p <0,05) higher than the figure in control. After 28 days of administration of omeprazole in rats increased serum concentration of TNF-α. This increase was 73,3% (p <0,05). The group of rats given the long-term co-administration of omeprazole and multiprobiotic drugs "Symbiter" and "Apibact" concentrations of TNF-α showed the rats serum decrease to 15,4% (p <0,05) and 17,9% (p <0,05), respectively, compared with the group of rats, which were injected only omeprazole during the same time. Compared with the control group of rats, the rats administered both omeprazole multiprobiotics "Symbiter" and "Apibact" during 28 days indicated that the concentration of TNF-α in serum of the rats serum remained respectively 46,7% (p <0,05) and 42,2% (p <0,05) higher. After 28-day administration of omeprazole to rats the concentration of pro-inflammatory cytokine IL-1β increased 80,2% (p <0,05) compared with the control group. After a 28-day co-administration of omeprazole and rats multiprobiotic "Symbiter" concentration of IL-1β in serum decreased to 22,5% (p <0,05) compared with the group of rats which were administered one of omeprazole and by 39,6% more (p <0,05) compared with the concentration of IL-1β in the serum of the rats in the control group. The rats injected multiprobiotic "Apibact" and omeprazole during 28 days displayed the concentration of IL-1β in serum at 40,5% (p <0,05) which is lower than the group of rats administered only omeprazole, and not significantly different from the rate of the control group rats. After 28-day administration of omeprazole the concentration of anti-inflammatory cytokine IL-4 in the rats serum was reduced by 39.8% (p <0.001) compared with control group rats. Adding to omeprazole multiprobiotic "Symbiter" or "Apibact" prevented the decrease in the concentration of IL-4 in the rats serum. Under these conditions, the concentration of IL-4 was the same as in the control group of rats. Long hipoatsydnist gastric juice induced omeprazole not to affect the concentration of the pro-inflammatory cytokine IL-6 in the blood serum of rats. Concomitant administration of omeprazole and multiprobiotic drugs to rats during the 28-day also rendered the effect of the concentration of IL-6 in rats blood serum. After 28-day administration of omeprazole concentration of IL-10 in the rats blood serum grew by 44.4% (p <0.01) compared with the control group of rats. Concomitant administration of omeprazole and multiprobiotic "Symbiter" or "Apibact" to rats during the 28-day prevented the increase in the concentration of IL-10 in the serum of rats. After 28-day administration of omeprazole the concentration of pro-inflammatory cytokine IL-12 in rats blood serum 40r reduced to 36,6% (p <0,01) compared with control group of rats. Conclusions. Inhibition of hydrochloric acid secretion in the rats stomach during the 28-day omeprazole injection resulted in the imbalance between pro- and anti-inflammatory cytokines, inflammatory cytokines concentration of IFN-γ, TNF-α, IL-1β significantly increased, IL-12 decreased 40r, and IL-6 unchanged. At the same time, changing the concentration of anti-inflammatory cytokines was the following IL-4 concentration has reduced, and IL-10 concentration has increased. Prolonged administration of multiprobiotic drugs on the background of gastric hypochlorhydria significantly reduced signs of inflammation in the mucous membranes of the stomach and colon, manifested in normalizing the balance between pro- and anti-inflammatory cytokines.

Keywords: inflammation, cytokines, serum, multiprobiotics, hypoacidity of gastric juice, omeprazole

Full text: PDF (Ukr) 349K

References
  1. Babin VN, Domaradskiy IV, Dubinin AV, Kondrakova OA. Biokhimicheskiye i molekulyarnyye aspekty simbioza cheloveka i yego mikroflory. Rossiyskiy khimicheskiy zhurnal. 1994; 38 (6): 66-78. [Russian].
  2. Mayanskiy AL, Mayanskiy NA, Zaslavskaya MI. Nuklearnyy faktor kB i vospaleniye. Tsitokiny i vospaleniye. 2007; 6 (2): 3-9. [Russian].
  3. Royt A, Brostoff Dzh, Meyl D. Immunologiya. M: Mir; 2000. 592 s. [Russian].
  4. Aubé AC. Blottiére HM, Scarpignato C. Inhibition of acetylcholine induced intestinal motility by interleukin 1β in the rat. Gut. 1996: 39 (3): 470-4.
  5. Aubé AC, Cherbut C, Rozé C. Vasoactive intestinal peptide is involved in the inhibitory effect of interleukin-1 beta on the jejunal contractile response induced by acetylcholine. Gastroenterol Clin Biol. 2001; 25 (12): 1090-5.
  6. Barnett MPG, McNabb WC, Cookson AL. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010; 11: 39. Available from: http://www.biomedcentral.com/1471-2172/11/39.
  7. Chan DW. Perlstein NT. Immunoassay. A Practical Guide, Eds., Academic Press: New York; 1987. 71 р.
  8. Russo F, Jirillo E, Clemente C, Messa C, Chiloiro M, Riezzo G, Amati L, Caradonna L, Di Leo A. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol Immunotoxicol. 2001; 1: 13-24. https://www.ncbi.nlm.nih.gov/pubmed/11322645. https://doi.org/10.1081/IPH-100102563
  9. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1; 75 (1): 40–7. https://www.ncbi.nlm.nih.gov/pubmed/2294996
  10. Elliott D. The substance P and somatostatin interferon-gamma immunoregulatory circuit. Ann NY Acad Sci. 1998; 240: 532-9.
  11. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut. 2001; 48: 743-7.
  12. Karttunen RA, Karttunen TJ, Yousfi MM, el-Zimaity HM, Graham DY, el-Zaatari FA. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol. 1997 Jan; 32 (1): 22–7. https://www.ncbi.nlm.nih.gov/pubmed/9018762. https://doi.org/10.3109/00365529709025058
  13. Birkholz, S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol. Med. Microbiol. 1993; 6: 317-24.
  14. Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, Covacci A Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol. 1995; 48: 967-9. https://www.ncbi.nlm.nih.gov/pubmed/8537502. https://www.ncbi.nlm.nih.gov/pmc/articles/502959
  15. Konturek PC, Brzozowski T, Konturek SJ, Kwiecien S, Dembinski A, Hahn EG. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rats. Scand J Gastroenterol. 2001; 36: 1239-47.
  16. Brzozowski T, Zwolinska-Wcislo M, Konturek PC, Kwiecien S, Drozdowicz D, Konturek SJ, Stachura J [et al]. Influence of gastric colonization with Candida albicans on ulcer healing in rats: effect of ranitidine, aspirin and probiotic therapy. Scand J Gastroenterol. 2005; 40 (3): 286-96. https://www.ncbi.nlm.nih.gov/pubmed/15932169
  17. Montuschi P, Tringali G, Parente L, Preziosi P, Navarra P. Interleukin-1 beta- and tumour-necrosis-factor-induced inhibition of rat gastric fundus motility in vitro. Pharmacol Res. 1994; 30: 25–33.
  18. Koscielni A, Kalff JC. T-helper C type 1 memory cells and postoperative ileus in the entire gut. Curr Opin Gastroenterol. 2011; 27 (6): 509-14.
  19. Lawley TD, Walker AW. Intestinal colonization resistance. Immunology. 2013; 138 (1): 1-11.
  20. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009; 15 (2): 300-10. https://doi.org/10.1002/ibd.20602
  21. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994; 9: 425-9.
  22. Karlsson Helen, Larsson Pia, Wold Agnes E, Rudin Anna. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differenciate into dendritic cells. Infect Immun. 2004; 72 (5): 2671-8. https://doi.org/10.1128/IAI.72.5.2671-2678.2004
  23. Kindt S, Vanden Berghe P, Boesmans W, Roosen L, Tack J. Prolonged IL-1beta exposure alters neurotransmitter and electrically induced Ca(2+) responses in the myenteric plexus. Neurogastroenterol Motil. 2010; 22 (3): 321–31. https://doi.org/10.1111/j.1365-2982.2009.01414.x
  24. Schoenborn JR, Wilson CB. Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol. 2007; 96: 41–101.
  25. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol. 2008; 14 (27): 4280–8.
  26. Ruyssers NE, De Winter BY, De Man JG. Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol. 2010; 16 (6): 703–12.
  27. Suzuki F, Grand E, Bowman C. TNF-alpha and interleukin 1 activate gastrin gene expression via MAPK- and PKC-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol. 2001; 281 (6): G1405-1412.
  28. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J [et al]. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 2001; 412: 99.
  29. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4: 71-8. https://doi.org/10.1038/nrc1256
  30. Wang TC, Golderring JR. Inflammation intersection: gp 130 balances gut irritation and stomach cancer. Nature Medicine. 2002; 8 (10): 1080-2.